Outlook Therapeutics, Inc. (OTLK)
0.3511
+0.01
(+4.43%)
USD |
NASDAQ |
Mar 20, 16:00
0.35
0.00 (0.00%)
After-Hours: 20:00
Outlook Therapeutics EPS Diluted (Quarterly) : -0.383 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | -0.014 |
| Amicus Therapeutics, Inc. | 0.0054 |
| CorMedix, Inc. | 0.1493 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.06M |
| Revenue (Quarterly) | -1.208M |
| Total Expenses (Quarterly) | 21.85M |
| Enterprise Value | 57.38M |
| Earnings Yield | -487.8% |
| Normalized Earnings Yield | -534.55 |